Buy Crypto
Pay with
USD
USD
Buy & Sell
Hot
Supports Visa, Mastercard, SEPA & more
P2P
0 Fees
Flexible trading, zero fees
Gate Card
Use your crypto for payments worldwide
Markets
Trade
Basic
Advanced
Futures
Futures
Access hundreds of perpetual contracts
CFD
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Stocks
CFD
Stock CFD Derivatives
US Stocks
Access real US stocks and ETFs
HK Stocks
Trade quality Hong Kong-listed stocks
Korean Stocks
SK Hynix
Real Korean stocks and top assets
Stock Futures
High leverage, 24/7 trading
Tokenized Stocks
Backed by real stock assets
IPO Access
Unlock full access to global stock IPOs
GUSD
3.8%
Mint GUSD for Treasury RWA yields
Stocks Activities
Trade Popular Stocks and Unlock Generous Airdrops
Earn
Launch
CandyDrop
tag
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
IPO Access
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Investment
Square
Square
Post, share, and explore crypto trends
Live
moments live
Live crypto market analysis
Chat
Chat with crypto traders
News
What is happening in crypto
flower_head
More
Promotions
AI
Others
TradFi
2026 World Cup
Rewards
Square
Latest
Hot
News
Profile

Accendra Health (ACH) was named one of the 15 best NYSE penny stocks

CoinNetwork
robot
Abstract generation in progress
Crypto market network news: Accendra Health (NYSE: ACH) was named one of the 15 best NYSE penny stocks. On June 23, Accendra Health announced the completion of the final settlement of its 4.5% and 6.625% senior notes, which have been replaced by new 9% and 9.75% preferred secured notes. Accendra expects to issue approximately $539.25 million of first-lien notes and approximately $698.1 million of second-lien notes. On June 17, S&P Global Ratings confirmed the company’s 'B' issuer credit rating and adjusted the outlook from negative to stable, while setting the second-lien notes rating at 'CCC+' and the first-lien notes rating at 'B+'. The outlook noted that near-term earnings will be pressured by acquisition and separation costs, but credit metrics are expected to improve. Accendra Health provides healthcare solutions, including diabetes medications and home care.
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • 4
  • 2
  • Share
Comment
Add a comment
Add a comment
L2AlleyRunner
· 5h ago
From 9% down to 4.5% on notes—saving on interest is like having a money-printing machine. Once the pain of M&A is weathered, it’s light equipment for the next stage.
View OriginalReply0
DaoSideQuest
· 6h ago
An S&P outlook upgrade to positive is more tangible than almost anything else; crypto people have gotten used to blowups, so this traditional finance “restoration” narrative feels fresh.
View OriginalReply0
Stop-LossAtTheEdgeOfTheLava
· 6h ago
$539 million first seizure + $698 million second seizure; leverage is maxed out—short-term profitability pressure is in line with expectations.
View OriginalReply0
OrderbookOtter
· 6h ago
Penny stocks are all about the heart-pounding adrenaline; once this one finishes its debt restructuring, the credit rating should be solid—consider it a signal.
View OriginalReply0

  • Pinned

Sitemap